As is reported, ALDH1A is linked to retinoic acid signaling and all-trans retinoic acid (ATRA), as a potential targeted therapy against cancer stem cells, could inhibit ALDH1A1 activity to improve chemotherapeutic efficacy [23, 24]. This evidence concerns the gene ALDH1A1 and cancer.